CHICAGO (WGN) — About 90% of the U.S. population has gotten their two-dose regimen to protect against measles, mumps and rubella, but, the unvaccinated have increasingly been contracting the highly ...

A new study suggests that low-dose radiation therapy could fill the treatment gap between pain medications and joint ...

Guselkumab offers the flexibility of self-administration from the start of treatment in both ulcerative colitis (UC) and Crohn’s disease (CD),1,2,3 providing the simplicity of a fully subcutaneous ...

Please provide your email address to receive an email when new articles are posted on . The regimen conferred a 71% complete response rate among older adults with newly diagnosed DLBCL. Median PFS and ...

Xencor's clear cell renal cell carcinoma treatment demonstrated evidence of anti-tumor activity in a phase 1 trial.

Biogen BIIB announced that the FDA has issued a complete response letter (CRL) to its supplemental new drug application (sNDA) seeking label expansion for a higher dose of its renowned spinal muscular ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. CHICAGO (WGN) — About 90% of the U.S.